FSD Pharma Inc. Announces Share Consolidation and Name Change
Ticker: QNTM · Form: 6-K · Filed: Aug 12, 2024 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Fsd Pharma Inc. (QNTM) |
| Form Type | 6-K |
| Filed Date | Aug 12, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, share-consolidation, name-change
TL;DR
FSD Pharma is consolidating shares and changing its name, effective August 9, 2024.
AI Summary
FSD Pharma Inc. announced on August 9, 2024, a share consolidation and a name change. These changes are detailed in a press release incorporated into their SEC filings. The company is incorporated in Canada and operates in the Pharmaceutical Preparations sector.
Why It Matters
Share consolidations and name changes can signal significant corporate restructuring or strategic shifts, potentially impacting investor perception and stock trading dynamics.
Risk Assessment
Risk Level: medium — Share consolidations can sometimes be a precursor to delisting or a sign of financial distress, while name changes can be for rebranding or to reflect new business directions.
Key Numbers
- 001-39152 — SEC File Number (Identifies the company's filings with the SEC)
Key Players & Entities
- FSD Pharma Inc. (company) — Registrant
- August 9, 2024 (date) — Announcement date of share consolidation and name change
- 2834 (other) — Standard Industrial Classification for Pharmaceutical Preparations
- Toronto, Ontario (location) — Principal executive office location
FAQ
What is the effective date of the share consolidation and name change?
The press release announcing these changes was issued on August 9, 2024.
What is FSD Pharma Inc.'s Standard Industrial Classification code?
FSD Pharma Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where are FSD Pharma Inc.'s principal executive offices located?
The company's principal executive offices are located at 199 Bay St., Suite 4000, Toronto, Ontario, Canada.
Does FSD Pharma Inc. file annual reports under Form 20-F or Form 40-F?
FSD Pharma Inc. files annual reports under Form 20-F.
What is the purpose of the press release mentioned in the filing?
The press release announces a share consolidation, name change, and other matters related to the company.
Filing Stats: 236 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2024-08-12 06:03:52
Filing Documents
- fsd_6k.htm (6-K) — 11KB
- fsd_ex991.htm (EX-99.1) — 21KB
- 0001654954-24-010266.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. FSD Pharma Inc. (Registrant) Date: August 9, 2024 By: /s/ Nathan Coyle Nathan Coyle, Chief Financial Officer 2 Exhibit Description 99.1 Press Release dated August 9 2024 – FSD Pharma Inc. Announces Share Consolidation and Name Change 3